-
IGXT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
IntelGenx Technologies (IGXT)
Company Profile
Quarter (USD) | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.28 mm | 2.28 mm | 2.28 mm | 2.28 mm | 2.28 mm | 2.28 mm |
Cash burn (monthly) | (no burn) | (no burn) | 657.00 k | 790.92 k | 175.33 k | 543.75 k |
Cash used (since last report) | n/a | n/a | 7.74 mm | 9.32 mm | 2.07 mm | 6.41 mm |
Cash remaining | n/a | n/a | -5.46 mm | -7.04 mm | 215.55 k | -4.13 mm |
Runway (months of cash) | n/a | n/a | -8.3 | -8.9 | 1.2 | -7.6 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 135.53 mm |
Total shares | 233.68 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
ATAI Atai Life Sciences | 233.68 mm | $135.53 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 24 | Bernd Josef Melchers | Restricted Share Units (p.v.0.00001) Common Stock | Grant | Acquire A | No | No | 0 | 111,783 | 0.00 | 111,783 |
29 Jan 24 | Mark Nawacki | Restricted Share Units (p.v.0.00001) Common Stock | Grant | Acquire A | No | No | 0 | 111,783 | 0.00 | 111,783 |
29 Jan 24 | Karen Kalayajian | Restricted Share Units (p.v.0.00001 ) Common Stock | Grant | Acquire A | No | No | 0 | 97,925 | 0.00 | 137,925 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 508,750 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 465,000 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 415,000 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 371,250 |
29 Jan 24 | Clemens Mayr | Restricted Share Units (p.v.0.00001) Common Stock | Grant | Acquire A | No | No | 0 | 92,510 | 0.00 | 111,783 |